Mpox Epidemiology and Vaccine Effectiveness, England, 2023.

Authors: Charles, Hannah¹, hannah.charles@ukhsa.gov.uk, Thorley, Katie¹, Turner, Charlie¹, Bennet, Kirsty F.¹, Andrews, Nick¹, Bertran, Marta¹, Mandal, Sema¹, Amirthalingam, Gayatri¹, Ramsay, Mary E.¹, Mohammed, Hamish¹, Sinka, Katy¹

Source: Emerging Infectious Diseases; Oct2024, Vol. 30 Issue 10, p2145-2148, 4p

Monoclonal Antibodies in Light of Mpox Outbreak: Current Research, Therapeutic Targets, and Animal Models.

Authors: Nikitin, Vladimir N.¹ (AUTHOR), Merkuleva, Iuliia A.¹ (AUTHOR) merkuleva_yua@vector.nsc.ru, Shcherbakov, Dmitriy N.¹ (AUTHOR)

Source: Antibodies (2073-4468). Mar2025, Vol. 14 Issue 1, p20. 23p.

Subject Terms: *VIRUS diseases, *MONKEYPOX, *MONKEYPOX vaccines, *VIRAL proteins, *VACCINATION mandates

Mpox Diagnosis, Behavioral Risk Modification, and Vaccination Uptake among Gay, Bisexual, and Other Men Who Have Sex with Men, United Kingdom, 2022.

Authors: Ogaz, Dana^1,2, dana.ogaz@ukhsa.gov.uk, Enayat, Qudsia¹, Brown, Jack R. G.², Phillips, Dawn¹, Wilkie, Ruth¹, Jayes, Danielle¹, Reid, David^2,3, Hughes, Gwenda^1,2,4, Mercer, Catherine H.^2,3, Saunders, John^1,2,3, Mohammed, Hamish^1,2

Source: Emerging Infectious Diseases; May2024, Vol. 30 Issue 5, p916-925, 10p

History Lessons.

Authors: EBIKEME, CHARLES (AUTHOR)

Source: Scientific American. Nov2024, Vol. 331 Issue 4, pS25-S27. 3p. 1 Cartoon or Caricature.

Subjects: SEXUALLY transmitted diseases, HEALTH facilities, VACCINATION, MONKEYPOX, COVID-19 pandemic, SMALLPOX

Advancing the understanding and management of Mpox: insights into epidemiology, disease pathways, prevention, and therapeutic strategies.

Authors: Hajjo, Rima^1,2,3 (AUTHOR) r.hajjo@zuj.edu.jo, Abusara, Osama H.¹ (AUTHOR), Sabbah, Dima A.¹ (AUTHOR), Bardaweel, Sanaa K.⁴ (AUTHOR)

Source: BMC Infectious Diseases. 4/15/2025, Vol. 25 Issue 1, p1-23. 23p.

Subject Terms: *MEDICAL sciences, *MONKEYPOX, *MEDICAL microbiology, *ZOONOSES, *DRUG discovery

Monkeypox virus H3L protein as the target antigen for developing neutralizing antibody and serological assay.

Authors: Huang, I-Hsiang¹ (AUTHOR), Lai, Guan-Chun¹ (AUTHOR), Chao, Tai-Ling² (AUTHOR), Liu, Wang-Da^3,4 (AUTHOR), Chang, Sui-Yuan^2,5 (AUTHOR) sychang@ntu.edu.tw, Chang, Shih-Chung^1,6 (AUTHOR) shihchung@ntu.edu.tw

Source: Applied Microbiology & Biotechnology. 4/2/2025, Vol. 109 Issue 1, p1-12. 12p.

Subject Terms: *CELL receptors, *MONKEYPOX, *VIRAL proteins, *MEDICAL sciences, *CELL surface antigens, *MONOCLONAL antibodies

Mpox-XDE: an ensemble model utilizing deep CNN and explainable AI for monkeypox detection and classification.

Authors: Kumar Saha, Dip¹ (AUTHOR) dip9178@gmail.com, Rafi, Sadman² (AUTHOR) sadman@ius.edu.bd, Mridha, M. F.² (AUTHOR) firoz.mridha@aiub.edu, Alfarhood, Sultan³ (AUTHOR) sultanf@ksu.edu.sa, Safran, Mejdl³ (AUTHOR) mejdl@ksu.edu.sa, Kabir, Md Mohsin⁴ (AUTHOR) md.mohsin.kabir@mdu.se, Dey, Nilanjan⁵ (AUTHOR) nilanjan.dey@tint.edu.in

Source: BMC Infectious Diseases. 3/25/2025, Vol. 25 Issue 1, p1-19. 19p.

Subject Terms: *TRANSFORMER models, *MONKEYPOX, *SKIN imaging, *DEEP learning, *ARTIFICIAL intelligence

Antiviral Effects of Tecovirimat and Cellular Ultrastructural Changes in Human Bronchial Epithelial Cell Line Following Monkeypox Virus Infection.

Authors: Falasca, Laura¹ (AUTHOR), Mija, Cosmina² (AUTHOR), Sberna, Giuseppe^2,3 (AUTHOR), Francalancia, Massimo^3,4 (AUTHOR), Meschi, Silvia^2,5 (AUTHOR), Mazzotta, Valentina^1,4 (AUTHOR), Girardi, Enrico^2,5 (AUTHOR), Antinori, Andrea^3,4 (AUTHOR), Maggi, Fabrizio^2,4 (AUTHOR), Bordi, Licia^2,5 (AUTHOR) licia.bordi@inmi.it

Source: International Journal of Molecular Sciences. Mar2025, Vol. 26 Issue 6, p2718. 15p.

Subject Terms: *MONKEYPOX, *VIRUS diseases, *SYMPTOMS, *MITOCHONDRIAL pathology, *CELL culture, *LUNGS

Geographical distribution and the impact of socio-environmental indicators on incidence of Mpox in Ontario, Canada.

Authors: Ugwu, Chigozie Louisa J.¹ (AUTHOR), Asgary, Ali² (AUTHOR), Wu, Jianhong¹ (AUTHOR), Kong, Jude Dzevela^3,4,5 (AUTHOR), Bragazzi, Nicola Luigi^1,6,7 (AUTHOR), Orbinski, James⁸ (AUTHOR), Woldegerima, Woldegebriel Assefa¹ (AUTHOR) wassefaw@yorku.ca

Source: PLoS ONE. 3/11/2025, Vol. 20 Issue 3, p1-27. 27p.

Subject Terms: *MONKEYPOX, *SCAN statistic, *STATISTICAL significance, *AKAIKE information criterion, *SOCIAL marginality

Monkeypox Virus Occurrence in Wastewater Environment and Its Correlation with Incidence Cases of Mpox: A Systematic Review and Meta-Analytic Study.

Authors: Omatola, Cornelius A.^1,2 (AUTHOR), Ogunsakin, Ropo E.^2,3 (AUTHOR), Olaniran, Ademola O.^3,4 (AUTHOR), Kumari, Sheena^1,4 (AUTHOR)

Source: Viruses (1999-4915). Mar2025, Vol. 17 Issue 3, p308. 17p.

Subject Terms: *MONKEYPOX, *COMMUNICABLE diseases, *SIMIAN viruses, *COVID-19 pandemic, *SEWAGE

Residual Immunity from Smallpox Vaccination and Possible Protection from Mpox, China.

Authors: Yu Huang^1,2, Li Guo^1,3,4,5, Yanan Li^1,4, Lili Ren^1,3,4,5, Jiqin Nie^1,4, Fengwen Xu^1,2, Tingxuan Huang^1,4, Jingchuan Zhong^1,4, Zhangling Fan^1,2, Yin Zhang¹, Yu Xie^1,2, Qiao Zhang¹, Shan Mei^1,2, Yan Xiao^1,4, Xinming Wang^1,4, Liuhui Xu^1,4, Fei Guo^1,2,5, guofei@ipb.pumc.edu.cn, Jianwei Wang^1,3,4,6, wangjw28@163.com

Source: Emerging Infectious Diseases; Feb2024, Vol. 30 Issue 2, p321-324, 4p

Genomic and Antigenic Differences Between Monkeypox Virus and Vaccinia Vaccines: Insights and Implications for Vaccinology.

Authors: Shen-Gunther, Jane¹ (AUTHOR), Cai, Hong^2,3 (AUTHOR), Wang, Yufeng^2,3 (AUTHOR) yufeng.wang@utsa.edu

Source: International Journal of Molecular Sciences. Feb2025, Vol. 26 Issue 4, p1428. 20p.

Subject Terms: *VACCINIA, *MONKEYPOX vaccines, *MONKEYPOX, *VIRAL antigens, *VIRAL vaccines

A retrospective chart review and thematic analysis of patients seeking mpox vaccination during the initial outbreak in 2022–2023: evaluation of access, motivations, and stigma.

Authors: Muncaster, Kody¹ (AUTHOR), Masterman, Chelsea^1,2 (AUTHOR), Barnett, Tamara¹ (AUTHOR), Kozak, Robert A.³ (AUTHOR), Mandel, Erin¹ (AUTHOR), Campbell, Karen¹ (AUTHOR), Biondi MJ, Mia J.^1,2 (AUTHOR) mbiondi@yorku.ca

Source: BMC Public Health. 12/18/2024, Vol. 24 Issue 1, p1-8. 8p.

Subject Terms: *MONKEYPOX vaccines, *PATIENTS' attitudes, *GENDER, *PUBLIC health, *MONKEYPOX

WHO's Health Emergencies Programme: acute emergencies monthly summary -- February-March 2025.

Alternate Title: Programme OMS de gestion des situations d'urgence sanitaire: résumé mensuel des situations d'urgence aiguë -- février-mars 2025.

Source: Weekly Epidemiological Record; 4/11/2025, Vol. 100 Issue 15, p123-129, 7p

Report of the 4th joint meeting of the WHO Global Advisory Committee on Vaccine Safety and the Advisory Committee on Safety of Medicinal Products, 12-14 November 2024.

Alternate Title: Rapport de la 4e réunion conjointe du Comité consultatif mondial de l'OMS pour la sécurité des vaccins et du Comité consultatif de l'OMS sur la sécurité des produits médicaux, 12-14 novembre 2024.

Source: Weekly Epidemiological Record; 3/7/2025, Vol. 110 Issue 10, p75-86, 12p

طراحی ایمونوانفورماتیکی کاندید واکسن چند اپیتوپی علیه ویروس آبله میمون از پروتئین پوکسین-شلافن

Alternate Title: Immunoinformatics Design of a Multi-Epitope Vaccine Candidate via Poxin-Schlafen Protein of Monkeypox Virus.

Authors: Ehsasatvatan, Maryam¹, Kohnehrouz, Bahram Baghban², Nejad, Fedra Nejad Iran³ nejadiran.f@gmail.com

Source: Journal of Rafsanjan University of Medical Sciences. 2025, Vol. 24 Issue 1, p19-46. 28p.

Subject Terms: *MONKEYPOX, *VACCINES, *B cells, *ORTHOPOXVIRUSES, *EPITOPES, *BIOINFORMATICS, *T cells

From pox to protection: understanding Monkeypox pathophysiology and immune resilience.

Authors: Ganesan, Alagammai¹ (AUTHOR) alagammaiganesan2103@gmail.com, Arunagiri, Thirumalai¹ (AUTHOR) thiru0811a@gmail.com, Mani, Suganandhini¹ (AUTHOR) suga.mani2122@gmail.com, Kumaran, Vamsi Ravi¹ (AUTHOR) rvamsi3180@gmail.com, Kannaiah, Kanaka Parvathi¹ (AUTHOR) kanakaparvathireddy.k@gmail.com, Chanduluru, Hemanth Kumar¹ (AUTHOR) hemanth.kumar361@gmail.com

Source: Tropical Medicine & Health. 2/26/2025, Vol. 53 Issue 1, p1-12. 12p.

Subject Terms: *MEDICAL sciences, *MONKEYPOX, *BIOTECHNOLOGY, *SYMPTOMS, *NATURAL immunity

First Clade Ib Monkeypox Virus Infection Reported in the Americas — California, November 2024.

Authors: Levy, Vivian^1,2, Branzuela, Anna¹, Hsieh, Kristina¹, Getabecha, Shiffen³, III, Ricardo Berumen³, Saadeh, Kayla³ Kayla.saadeh@cdph.ca.gov, Snyder, Robert E.³, Marek, Gillian³, Dodson, Daniel³, Newman, Alyssa³, Hacker, Jill K.³, Kath, Chantha³, Minhaj, Faisal S.⁴, Gigante, Crystal M.⁴, Gearhart, Shannon⁵, Kallen, Alexander⁶, Hutson, Christina L.⁴, Jacobson, Kathleen³

Source: MMWR: Morbidity & Mortality Weekly Report. 2/13/2025, Vol. 74 Issue 4, p44-49. 6p.

Subject Terms: *MONKEYPOX, *LABORATORY reports, *POLYMERASE chain reaction, *PUBLIC health

Geographic Terms: CALIFORNIA, CONGO (Democratic Republic)

Fluorescent Clade IIb Lineage B.1 Mpox Viruses for Antiviral Screening.

Authors: Alvarez-de Miranda, Francisco Javier¹ (AUTHOR), Martín, Rocío¹ (AUTHOR), Alcamí, Antonio¹ (AUTHOR), Hernáez, Bruno¹ (AUTHOR) bhernaez@cbm.csic.es

Source: Viruses (1999-4915). Feb2025, Vol. 17 Issue 2, p253. 12p.

Subject Terms: *MONKEYPOX, *VIRAL transmission, *CYTARABINE, *FLUORESCENT proteins, *VIRAL genomes

Multi-Classification of Skin Lesion Images Including Mpox Disease Using Transformer-Based Deep Learning Architectures.

Authors: Vuran, Seyfettin¹ (AUTHOR) svuran@dicle.edu.tr, Ucan, Murat² (AUTHOR) murat.ucan@dicle.edu.tr, Akin, Mehmet³ (AUTHOR) makin@dicle.edu.tr, Kaya, Mehmet⁴ (AUTHOR) kaya@firat.edu.tr

Source: Diagnostics (2075-4418). Feb2025, Vol. 15 Issue 3, p374. 19p.

Subject Terms: *MONKEYPOX, *SKIN imaging, *DEEP learning, *TRANSFORMER models, *DIAGNOSIS